Nishant Shekhar

发表

Drug targets for corona virus: A systematic review

B. Medhi, P. Avti, P. Sarma, 2020, Indian journal of pharmacology.

Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD

B. Medhi, P. Avti, P. Sarma, 2021, Computers in Biology and Medicine.

Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: A systematic review and meta‐analysis

Ashutosh Kumar Singh, A. Prakash, B. Medhi, 2020, Journal of medical virology.

Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis

A. Prakash, B. Medhi, P. Avti, 2020, Indian journal of pharmacology.

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

A. Prakash, B. Medhi, P. Sarma, 2021, Pharmacological reports : PR.

Efficacy and safety of topical cysteamine in corneal cystinosis: a systematic review and meta- analysis.

A. Prakash, B. Medhi, P. Avti, 2020, American journal of ophthalmology.

An insight into the simulation directed understanding of the mechanism in SARS CoV-2 N-CTD, dimer integrity, and RNA-binding: Identifying potential antiviral inhibitors

B. Medhi, Jitender Singh, P. Avti, 2021, Journal of biomolecular structure & dynamics.

Efficacy of green tea, its polyphenols and nanoformulation in experimental colitis and the role of non-canonical and canonical nuclear factor kappa beta (NF-kB) pathway: a preclinical in-vivo and in-silico exploratory study

A. Prakash, B. Medhi, P. Sarma, 2020, Journal of biomolecular structure & dynamics.

Computational attributes of protein kinase-C gamma C2-domain & virtual screening for small molecules: elucidation from meta-dynamics simulations & free-energy calculations

B. Medhi, P. Avti, Nishant Shekhar, 2022, Journal of biomolecular structure & dynamics.

In-silico discovery of dual active molecule to restore synaptic wiring against autism spectrum disorder via HDAC2 and H3R inhibition

B. Medhi, Nishant Shekhar, A. Prakash, 2022, PloS one.

In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy

B. Medhi, P. Sarma, Saniya Mahendiratta, 2020, Journal of advanced pharmaceutical technology & research.

Update on the target structures of SARS-CoV-2: A systematic review

Ajay Prakash, Pramod Avti, Manisha Prajapat, 2020, Indian journal of pharmacology.

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

A. Prakash, B. Medhi, P. Sarma, 2021, Pharmacological Reports.

In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations

A. Prakash, B. Medhi, P. Avti, 2020, mSystems.

Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings

A. Prakash, B. Medhi, P. Avti, 2021, Journal of biomolecular structure & dynamics.

Ocular Manifestations and Tear or Conjunctival Swab PCR Positivity for 2019-nCoV in Patients with COVID-19: A Systematic Review and Meta-Analysis

B. Medhi, P. Avti, P. Sarma, 2020, SSRN Electronic Journal.

Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19

B. Medhi, P. Sarma, Nishant Shekhar, 2021, Expert review of anti-infective therapy.

Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation

Ashutosh Kumar Singh, A. Kuhad, B. Medhi, 2023, Bioinformatics and biology insights.

Antiparasitic effect of Farnesol against Leishmania major: A rationale from in vitro and in silico investigations

Nishant Shekhar, Harshita Sharma, Rakesh Sehgal, 2023, PloS one.